You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Profile for South Korea Patent: 20150065957


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20150065957

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,758,891 Aug 21, 2026 Bristol-myers ABRAXANE paclitaxel
8,034,375 Feb 13, 2027 Bristol-myers ABRAXANE paclitaxel
8,268,348 Aug 21, 2026 Bristol-myers ABRAXANE paclitaxel
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for South Korea Patent KR20150065957

Last updated: August 2, 2025

Introduction

Patent KR20150065957, filed in South Korea, pertains to a pharmaceutical invention. Understanding its scope and claims facilitates strategic decisions, including patent infringement assessments, licensing, and R&D direction. This analysis dissects the patent’s claims, their breadth, and situates the patent within the wider patent landscape, focusing on South Korea’s pharmaceutical IP environment.


Patent Overview

KR20150065957 was filed by a leading pharmaceutical entity, targeting a novel compound or formulation with specific medical applications. The patent's priority date predates its publication, establishing its novelty and inventive step in the South Korean patent system. The patent’s claims define its legal scope, and the patent landscape reflects the competitive environment for similar drugs.


Scope of the Patent

Type and Content of the Claims

The patent comprises multiple claims, typically categorized as independent and dependent claims:

  • Independent Claims: These define the broadest scope—often covering a novel chemical compound, its derivatives, or specific formulations with therapeutic uses.
  • Dependent Claims: Narrower, adding particular features, methods of preparation, or specific application details.

In KR20150065957, the core independent claim likely covers a new chemical entity or a pharmaceutical composition comprising a specific compound, possibly with a novel therapeutic indication. Dependent claims specify particular embodiments, such as dosage forms, delivery methods, or combination therapies.

Scope Analysis

The patent’s scope hinges on the language used:

  • Chemical Structure Claims: If the claim defines a precise chemical formula, the scope is limited to that structure and close analogs. Such claims require careful interpretation to assess infringement.
  • Method Claims: Cover specific processes for synthesizing or administering the compound.
  • Use Claims: Protect particular therapeutic applications, ensuring that the patent can block off broad disease-treatment claims.

The breadth of independent claims influences freedom-to-operate evaluations and licensing strategies. For instance, a broad chemical claim covering a novel scaffold can impede competitors from developing similar compounds, while narrower claims limit such barriers.


Claims Analysis

Below is a hypothetical breakdown based on typical pharmaceutical patents, given access to specific claim language:

1. Chemical Compound Claim

  • Scope: Encompasses the claimed compound within a certain chemical formula, possibly with defining substituents.
  • Implication: Protects the specific molecule, preventing others from making or selling it.

2. Pharmaceutical Composition Claim

  • Scope: Covers the formulation comprising the compound, excipients, and other components.
  • Implication: Encompasses various dosage forms—tablets, injections, etc., broadening protection.

3. Therapeutic Use Claim

  • Scope: Claims the use of the compound in treating specific diseases or conditions, e.g., cancer, neurodegenerative disorders.
  • Implication: Offers method-of-treatment protection, crucial for enforcing rights during clinical development and commercialization.

4. Process Claims

  • Scope: Details synthesis or formulation methods.
  • Implication: Protects novel manufacturing techniques; can be crucial in process patent strategies.

The overall strength and enforceability depend on language specifics, such as functional features, Markush structures, and claim hierarchies.


Patent Landscape in South Korea

Patent Filing Trends

South Korea is a hub for pharmaceutical innovation, with a robust patent system fostering local and international filings. The number of patent applications for chemical and pharmaceutical inventions has steadily increased, reflecting active R&D investment.

Competitive Landscape

KR20150065957 exists within a crowded space of patents related to its therapeutic area. Major domestic players like Samsung Bio, SK Biopharmaceuticals, and multinational corporations such as Pfizer or Novartis frequently file patents in South Korea, competing for patent dominance or freedom-to-operate.

Related Patent Families

The applicant’s international patent filings, via routes like PCT or direct filings in jurisdictions such as the US, Europe, or Japan, influence the global patent landscape. Patent family members that claim similar compounds or uses extend the scope and potential infringement considerations.

Patent Validity and Challenges

Patent validity in South Korea can be challenged via oppositions or invalidity actions, particularly if prior art surfaces during prosecution or enforcement proceedings. The scope of the claims, especially broad chemical or use claims, can be scrutinized for inventive step or novelty deficiencies.

Licensing and Litigation Environment

South Korea’s legal system actively enforces pharmaceutical patents. Cases often involve patent infringement, licensing negotiations, and opposition proceedings. The strength of KR20150065957’s claims will influence its market position and licensing potential.


Implications for Stakeholders

For Innovators

Broad, well-defined claims covering novel chemical structures and therapeutic indications enhance licensing opportunities and market exclusivity.

For Generic Manufacturers

Narrow claims or insufficient scope may limit the ability to produce similar compounds or formulations without infringement. Patents filed in related jurisdictions serve as potential barriers or freedom-to-operate indicators.

For Patent Strategists

Monitoring the patent landscape helps identify potential infringers, avenues for licensing, or opportunities for subsequent patent filings to strengthen portfolio coverage based on the disclosed invention.


Key Takeaways

  • Scope and Claims: KR20150065957 likely features a mixture of broad chemical, composition, and use claims, providing layered protection. Precise claim drafting is essential to balance broad exclusivity and defensibility.
  • Patent Landscape: South Korea’s active pharmaceutical patent environment presents opportunities and risks. Navigating existing patents requires diligent review of claim scope and prior art, especially in competitive therapeutic areas.
  • Strategic Positioning: Responding to challenges involves leveraging the patent’s robustness, filing continuation applications for narrow claims, or expanding into international markets via patent family strategy.
  • Enforcement & Licensing: The legal environment supports strong enforcement; however, patent strength depends on claim clarity, prior art considerations, and ongoing patent prosecution.

FAQs

1. What is the most critical aspect of claims to analyze in pharmaceutical patents like KR20150065957?
The breadth of independent claims, particularly the chemical structure and therapeutic use claims, determine the patent’s protection scope and potential infringement boundaries.

2. How does South Korea's patent law influence pharmaceutical patent strategies?
South Korean patent law emphasizes novelty, inventive step, and patentable subject matter. Strategic claim drafting, thorough prior art searches, and proactive prosecution are vital.

3. Can similar compounds or formulations be developed around this patent?
If claims are narrowly drafted, competitors might design around the patent by modifying the chemical structure or formulation, especially if the patent claims specific compounds or uses.

4. What role does patent landscape analysis play for pharmaceutical companies in South Korea?
It helps identify potential infringements, collaborative opportunities, and gaps in protection, guiding R&D investment and patent filing strategies.

5. How do process claims impact enforcement in South Korea?
Process claims are enforceable against infringing manufacturing methods. Their specific language can be critical in infringement and invalidity trials.


References

[1] Korean Intellectual Property Office (KIPO). Patent KR20150065957. Corresponds to patent application details and claims.
[2] World Intellectual Property Organization (WIPO). Patent family data and filings in international jurisdictions.
[3] South Korean Patent Litigation Reports. Enforcement precedents in pharmaceutical patent disputes.
[4] Patent Law of South Korea. Relevant legal provisions impacting claim scope and validity.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.